Actively Recruiting

Phase Not Applicable
Age: 20Years - 60Years
All Genders
NCT06133712

Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief

Led by Tanta University · Updated on 2025-05-29

135

Participants Needed

1

Research Sites

108 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of the present study is to compare the analgesic efficacy of Dexmedetomidine, Ozone and Dexamethasone regional injection in carpal tunnel syndrome.

CONDITIONS

Official Title

Dexmedetomidine, Ozone and Dexamethasone Local Injection in Carpal Tunnel Syndrome for Pain Relief

Who Can Participate

Age: 20Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age from 20 to 60 years
  • Both sexes
  • Ultrasonographic evidence of mild-to-moderate carpal tunnel syndrome
  • Numbness and pain in median nerve area for at least 3 months
  • Nerve conduction studies consistent with carpal tunnel syndrome per guidelines
  • Median nerve cross-sectional area at wrist greater than 12 mm2 indicating mild-to-moderate CTS
Not Eligible

You will not qualify if you...

  • Patient refusal to participate
  • Severe carpal tunnel syndrome needing surgery
  • Improvement on medical treatment
  • Previous surgical or injection treatment for CTS
  • Pregnancy
  • Presence of brachial plexopathy, thoracic outlet syndrome, polyneuropathy, radiculopathy, or other peripheral nerve lesions in upper limb
  • Severe cardiovascular disease
  • Morbid obesity with BMI over 35 kg/m2
  • Infection at injection site
  • Bleeding disorders
  • History of thyroid deficiency, uncontrolled diabetes, rheumatoid arthritis, or G6PD deficiency
  • Allergy to Ozone or Dexmedetomidine
  • End-stage kidney or liver disease
  • History of inflammatory joint or connective tissue disorders, burns, local tissue contractures, or wrist trauma
  • Refusal to complete pain scale or nerve conduction studies before and after injection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Faculty of Medicine

Tanta, El Gharbia, Egypt, 31527

Actively Recruiting

Loading map...

Research Team

M

Mahmoud T Elgebaly, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here